Skip to main content

Table 2 Main clinical characteristics of the study subjects at December 31, 2013

From: Susceptibility to particle health effects, miRNA and exosomes: rationale and study protocol of the SPHERE study

Characteristics

N

 

BMI, Kg/cm2

1247

33.5 ± 5.5

BMI categorical

  

<30 Kg/cm2

 

347 (27.8%)

30-35 Kg/cm2

 

483 (38.6%)

≥35 Kg/cm2

 

420 (33.6%)

Waist circumference, cm

1237

101.3 ± 13.1

Blood pressure, mmHg

1247

 

Sistolic

 

125.4 ± 15.8

Diastolic

 

78.5 ± 9.5

Above 140/90 mmHg

 

60 (4.8%)

Below 140/90 mmHg

 

1190 (95.2%)

Heart rate, bpm

1243

67.6 ± 10.4

Uric acid

1163

5.2 ± 1.4

Fibrinogen, mg/dl

1129

335 ± 59

C-reactive protein

1160

0.3 [0.1-0.5]

Total cholesterol, mg/dl

1165

215.1 ± 41

HDL

 

59.2 ± 15.5

LDL

 

134.7 ± 36.3

Triglyceride

1164

107 [77–145.5]

Serum creatinine, mg/dL

1165

0.8 ± 0.3

AST, U/I

1159

19 [16–23]

ALT, U/I

1160

21 [16–30.5]

Gamma-Glutamyltransferase, IU/L

1162

19 [13–30]

Glucose

1155

92 [86–101]

Homocysteine

1151

10.4 [8.6–12.7]

TSH

1163

1.7 [1.2–2.5]

Glycated hemoglobin, mmol/mol

1159

39 [36.6–43]

Postprandial glycaemia, mg/dl

1162

99 [90–112]

Insulin level

1158

12.3 [8.8–18]

2-hour post glucose insulin level

1155

46.4 [27.6–73]

Urinary pH

1144

5.6 ± 0.7

Emocrome

1156

 

  White blood cells

 

6.8 ± 1.7

  Red blood cells

 

4.8 ± 0.4

  Hemoglobin

 

13.8 ± 1.4

  Hematocrit

 

40.7 ± 3.4

  Mean Corpuscolar Volume

 

85.1 ± 6.4

  Platelets

 

249.7 ± 59

  1. Continuous variable are expressed as mean ± standard deviation (SD) or as median [first quartile-third quartile] if not normally distributed; discrete variables are expressed as counts (%).